Axsome Therapeutics Reports Q2 2026 Financial Results

What Happened
Axsome Therapeutics, Inc. (NASDAQ: AXSM) filed a Form 8-K on August 10, 2026 to announce its financial results for the three months ended June 30, 2026. The company furnished a press release reporting those quarterly results and also updated and posted its corporate presentation on the company website.

Key Details

• Press release announcing results for the quarter ended June 30, 2026 was issued and furnished as Exhibit 99.1 (dated August 10, 2026).
• Updated corporate presentation was posted to Axsome’s website and filed as Exhibit 99.2.
• The Form 8-K was signed by President and CEO Herriot Tabuteau, M.D., dated August 10, 2026.
• The filing covers Item 2.02 (results of operations) and Item 8.01 (other events).

Why It Matters
Quarterly results and an updated corporate presentation provide investors with current financial performance data and management’s latest messaging on strategy or progress. Reviewing the attached press release and presentation will give retail investors the concrete revenue, expense, and operational details needed to assess Axsome’s recent performance and near-term outlook.